Massachusetts General Hospital
Danvers, Massachusetts, United States
Medical clinic in Danvers, Massachusetts
102-104 Endicott St, Danvers, MA 01923
About Massachusetts General Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Massachusetts General Hospital
During the past decade, Massachusetts General Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
1997-10-01
Completed
2,000
A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients
Completed
300
A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii Infection
1992-03-01
Completed
600
A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women
1995-12-01
Completed
400
A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected Patients
1996-11-01
Completed
2,500
A Study of Psychosocial and Behavioral Determinants of Differential Rates of Participant Compliance in CPCRA Protocols
1994-10-01
1996-09-01
Completed
557
A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.
1998-10-01
Completed
525
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Massachusetts General Hospital
According to Clinical.Site data, the most researched conditions in "Massachusetts General Hospital" are
"Breast Neoplasm" (1 trials), "Neoplasm Metastasis" (1 trials) and "Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Massachusetts General Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Massachusetts General Hospital
Most popular intervention types in "Massachusetts General Hospital" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Abemaciclib" (1 trials), "Fulvestrant" (1 trials), "Placebo" (1 trials) and "Prexasertib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Massachusetts General Hospital
The vast majority of trials in "Massachusetts General Hospital" are
2 trials for "All" genders.
Clinical Trials Status at Massachusetts General Hospital
Currently, there are NaN active trials in "Massachusetts General Hospital".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Massachusetts General Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Massachusetts General Hospital, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".